Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,651 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT04195698

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • University of Arkansas for Medical Sciences /ID# 221021 Little Rock, Arkansas, United States
  • Duplicate_First OC Dermatology Research Inc /ID# 218619 Fountain Valley, California, United States
  • UCSF Fresno /ID# 218453 Fresno, California, United States
  • California Allergy and Asthma Medical Group /ID# 218635 Los Angeles, California, United States
View all 116 locations
View Trial Details
Completed

Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)

NCT05253781

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +19 more
Locations
  • Ajeromi General Hospital, Ajegunle, Lagos State Ajegunle, Lagos, Nigeria
  • Federal Medical Centre, Ebute Metta, Lagos State Ebute-Metta, Lagos, Nigeria
  • Lagos University Teaching Hospital Idi-Araba, Lagos, Nigeria
  • Alimosho General Hospital, Igando, Lagos State Igando, Lagos, Nigeria
View all 16 locations
View Trial Details
Completed

HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)

NCT02485938

Conditions
Cardiomyopathies, Cardiomyopathy, Cardiovascular Diseases, +12 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Stacking Exercises Aid the Decline in FVC and Sick Time

NCT01999075

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Duchenne Muscular Dystrophy, Genetic Diseases, Inborn, +8 more
Locations
  • Alberta Children's Hospital Calgary, Alberta, Canada
  • Stollery Children's Hospital Edmonton, Alberta, Canada
  • BC Children's Hospital Vancouver, British Columbia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details
Completed

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

NCT01553149

Conditions
Astrocytoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 126 locations
View Trial Details
Completed

Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases

NCT05435638

Conditions
Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Soroka Medical Center Beersheba, Israel
  • Rabin Medical Center (Beilinson, Hasharon) Petah Tikva, Israel
  • Sourasky Medical Center - Ichilov Hospital Tel Aviv, Israel
View Trial Details
Completed

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

NCT03664804

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • CenExel Rocky Mountain Clinical Research, LLC Englewood, Colorado, United States
  • Georgetown University; Research Division, Psychiatry Washington D.C., District of Columbia, United States
  • Hereditary Neurological Disease Centre (HNDC) Wichita, Kansas, United States
  • John Hopkins University School of Medicine Baltimore, Maryland, United States
View all 15 locations
View Trial Details

Related conditions